quarta-feira, 7 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· May 23, 2026

Is It Too Late To Consider Ford (F) After Its 51% One Year Surge?

View original at finance.yahoo.com
Is It Too Late To Consider Ford (F) After Its 51% One Year Surge? Never miss an important update on your stock portfolio and cut through the noise…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • There are 49 additional high quality undervalued stocks identified beyond Ford Motor

    60% confidence
  • The P/S ratio is a useful valuation metric for companies generating meaningful revenue, especially when earnings are volatile or distorted by one-off items

    60% confidence
  • Ford Motor is currently generating trailing twelve month free cash flow of approximately $9.83 billion

    60% confidence
  • Projected free cash flow for Ford Motor in 2028 is $7.74 billion, with additional estimates extending through 2035

    60% confidence
  • Over 7 million investors trust Simply Wall St to stay informed about their stock portfolios

    60% confidence
  • Ford Motor stock returned 11.4% over the past week, 18.2% over the past month, 11.9% year-to-date, and 51.2% over the past year

    60% confidence
  • Ford Motor is undervalued by 13.8% based on DCF analysis, with an estimated intrinsic value of $17.33 per share versus a market price of approximately $14.93

    60% confidence
  • Ford Motor currently scores 4 out of 6 on Simply Wall St's valuation checks

    60% confidence
  • Ford Motor's 3-year return is 49.1% and 5-year return is 38.6%

    60% confidence

Data points we hold from this source

Ford Motor Company · cash7.74 USD
Ford Motor Company · stock price14.93 USD
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,362 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Is It Too Late To Consider Ford (F) After Its 51% One Year Surge? — Source | Via News | pt.VIA.NEWS